Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NorC is a 14-transmembrane-helix protein belonging to the major facilitator superfamily transporters, predominantly found in bacteria such as Staphylococcus aureus where it contributes to multidrug resistance by exporting various toxic compounds, including fluoroquinolone antibiotics, out of the cell. The transporter is evolutionarily related to other multidrug efflux pumps but forms a distinct clade with high sequence similarity to NorB. NorC does not efficiently transport some typical MFS substrates but binds organic cations like tetraphenylphosphonium. Structural studies have revealed drug-blocking strategies, such as the use of single-domain camelid antibodies that physically occlude the transporter’s substrate vestibule, making NorC a potential target for new resistance-breaking therapeutics.
Efflux of antibiotics and xenobiotics from bacterial cells, decreasing intracellular drug concentration and conferring resistance. Antibody-mediated blockade occurs when antibodies bind the extracellular domain, blocking access and inhibiting function.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily transporter NorC (NorC).